UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET

Journal of Nuclear Medicine, 2018-08, Vol.59 (8), p.1321-1328

2018

Volltextzugriff (PDF)

Nasopharyngeal tuberculosis incidentally diagnosed on 18F-FDG PET/CT

International journal of infectious diseases, 2020-04, Vol.93, p.295-296

2020

Volltextzugriff (PDF)

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

Nature communications, 2023-06, Vol.14 (1), p.3698-3698, Article 3698

2023

Volltextzugriff (PDF)

FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer

Annals of nuclear medicine, 2020-12, Vol.34 (12), p.968-974

2020

Volltextzugriff (PDF)

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab

Cancers, 2020-08, Vol.12 (8), p.2234

2020

Volltextzugriff (PDF)

Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)

Orphanet journal of rare diseases, 2021-01, Vol.16 (1), p.18-18, Article 18

2021

Volltextzugriff (PDF)

Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine

Diagnostics (Basel), 2021-04, Vol.11 (4), p.676

2021

Volltextzugriff (PDF)

Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy

Cancers, 2023-04, Vol.15 (8), p.2223

2023

Volltextzugriff (PDF)

Breast cancer recurrence diagnosis suspected on tumor marker rising

Cancer, 2011-04, Vol.117 (8), p.1621-1629

2011

Volltextzugriff (PDF)

Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer

Journal of clinical medicine, 2023-08, Vol.12 (17), p.5487

2023

Volltextzugriff (PDF)

Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response

Cancer imaging, 2020-01, Vol.20 (1), p.11-11, Article 11

2020

Volltextzugriff (PDF)

PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer

Journal of clinical medicine, 2023-07, Vol.12 (15), p.4882

2023

Volltextzugriff (PDF)

Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT

Diagnostics (Basel), 2021-04, Vol.11 (5), p.747

2021

Volltextzugriff (PDF)

18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab

Diagnostics (Basel), 2021-07, Vol.11 (8), p.1353

2021

Volltextzugriff (PDF)

Clinical Implications of 18F-FDG PET/CT in Malignant Glomus Tumors of the Esophagus

Clinical nuclear medicine, 2020-06, Vol.45 (6), p.e301

2020

Volltextzugriff (PDF)

Nasopharyngeal tuberculosis incidentally diagnosed on 18 F-FDG PET/CT

International journal of infectious diseases, 2020-04, Vol.93, p.295

2020

Volltextzugriff (PDF)

Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients

Journal of Nuclear Medicine, 2023-07, Vol.64 (7), p.1164-1165

2023

Volltextzugriff (PDF)

Metabolic Response by 18F-FDG PET/CT in Metastatic Malignant Struma Ovarii Treated With Targeted Therapies

Clinical nuclear medicine, 2021-01, Vol.46 (1), p.52

2021

Volltextzugriff (PDF)

Voxel‐wise supervised analysis of tumors with multimodal engineered features to highlight interpretable biological patterns

Medical physics (Lancaster), 2022-06, Vol.49 (6), p.3816-3829

2022

Volltextzugriff (PDF)

Potential Theranostic Role of Bone Marrow Glucose Metabolism on Baseline 18F-FDG PET/CT in Metastatic Melanoma

The Journal of nuclear medicine (1978), 2022-01, Vol.63 (1), p.166-166

2022

Volltextzugriff (PDF)

FDG-PET radiomic twins often share molecular subtype and hormonal receptor status in breast cancer patients

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.646

2018

Volltextzugriff (PDF)

Potential Theranostic Role of Bone Marrow Glucose Metabolism on Baseline 18 F-FDG PET/CT in Metastatic Melanoma

Journal of Nuclear Medicine, 2022-01, Vol.63 (1), p.166-166

2022

Volltextzugriff (PDF)

Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity

Cancer treatment reviews, 2024-03, Vol.124, p.102684-102684, Article 102684

2024

Volltextzugriff (PDF)

Spleen glucose metabolism on [18F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (8), p.2309-2311

2021

Volltextzugriff (PDF)

Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

Lung cancer (Amsterdam, Netherlands), 2021-09, Vol.159, p.45-55

2021

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(41)
Life Sciences
(28)
Humans
(26)
Breast Cancer
(22)
Positron Emission Tomography
(20)
Oncology
(18)
Patients
(18)
Tomography
(18)
Female
(16)
Radiology, Nuclear Medicine & Medical Imaging
(15)
Tumors
(15)
Cancer
(14)
Computed Tomography
(14)
Medical Imaging
(14)
Positron Emission
(14)
Fluorodeoxyglucose F18
(12)
Biomarkers
(11)
Chemotherapy
(11)
Imaging
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET

Nasopharyngeal tuberculosis incidentally diagnosed on 18F-FDG PET/CT

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab

Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)

Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine

Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy

Breast cancer recurrence diagnosis suspected on tumor marker rising

Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer

Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response

PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer

Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT

18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab

Clinical Implications of 18F-FDG PET/CT in Malignant Glomus Tumors of the Esophagus

Nasopharyngeal tuberculosis incidentally diagnosed on 18 F-FDG PET/CT

Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients

Metabolic Response by 18F-FDG PET/CT in Metastatic Malignant Struma Ovarii Treated With Targeted Therapies

Voxel‐wise supervised analysis of tumors with multimodal engineered features to highlight interpretable biological patterns

Potential Theranostic Role of Bone Marrow Glucose Metabolism on Baseline 18F-FDG PET/CT in Metastatic Melanoma

FDG-PET radiomic twins often share molecular subtype and hormonal receptor status in breast cancer patients

Potential Theranostic Role of Bone Marrow Glucose Metabolism on Baseline 18 F-FDG PET/CT in Metastatic Melanoma

Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity

Spleen glucose metabolism on [18F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients

Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

Suchergebnisse filtern